University of Alabama- Birmingham — Birmingham, Alabama

University of Alabama- Birmingham is a clinical research site located in Birmingham, Alabama, United States 35233.

Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.

University of Alabama- Birmingham has participated in 5 clinical trials.

Therapeutic areas: BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma, Locally Advanced Hepatocellular Carcinoma.

Sponsors: Academic and Community Cancer Research United, University of Pennsylvania, Gilead Sciences.

Sponsor Feasibility Report

Trust Score: 73/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Alabama- Birmingham?

University of Alabama- Birmingham has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Alabama- Birmingham conducted?

University of Alabama- Birmingham has 5 clinical trials on record. Their work covers BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma, Locally Advanced Hepatocellular Carcinoma.

Is University of Alabama- Birmingham accredited by Crixeo Health?

Yes — University of Alabama- Birmingham holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about University of Alabama- Birmingham?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.